A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer

• Shu-Fu Lin ,

  * E-mail: mmg@cgmh.org.tw

  Affiliation Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

  ⨯
• Jen-Der Lin,

  Affiliation Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

  ⨯
• Chuen Hsueh,

  Affiliation Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan

  ⨯
• Ting-Chao Chou,

  Current address: PD Science, Inc., Paramus, New York, United States of America

  Affiliation Laboratory of Preclinical Pharmacology Core, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Richard J. Wong

  Affiliation Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯